Brinton Pharmaceuticals Ltd. is a rapidly-growing pharmaceutical company with a global reach. Founded in 2014 and headquartered in India, Brinton is committed to enhancing lives through safe, economical, and innovative medical solutions. With a focus on meeting the evolving demands of people and healthcare professionals, Brinton boasts a rich and continually evolving portfolio and state-of-the-art resources in R&D, manufacturing, marketing, and sales.
The company's recent $8.00M Series B investment on 15 June 2019 from India Alternatives Private Equity Fund underscores its growth and potential. Brinton's global presence and dedicated team working on product enhancement, research, development, and marketing and sales capabilities position it well for continued success in the Biotechnology, Health Care, Pharmaceutical, and Marketing industries.
Brinton Pharmaceuticals Ltd.'s slogan, "Touching Lives Globally......", encapsulates its mission to positively impact lives worldwide and represents an attractive investment opportunity in the pharmaceutical sector.